These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9563163)

  • 1. Effects of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with inactivated vaccines containing the Apx toxins.
    Chiers K; van Overbeke I; De Laender P; Ducatelle R; Carel S; Haesebrouck F
    Vet Q; 1998 Apr; 20(2):65-9. PubMed ID: 9563163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with a vaccine containing Apx toxins and transferrin-binding proteins.
    Van Overbeke I; Chiers K; Ducatelle R; Haesebrouck F
    J Vet Med B Infect Dis Vet Public Health; 2001 Feb; 48(1):15-20. PubMed ID: 11254095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 10 of pigs vaccinated with bacterins consisting of A. pleuropneumoniae serotype 10 grown under NAD-rich and NAD-restricted conditions.
    van Overbeke I; Chiers K; Donne E; Ducatelle R; Haesebrouck F
    J Vet Med B Infect Dis Vet Public Health; 2003 Aug; 50(6):289-93. PubMed ID: 14629000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the role of antibodies to Actinobacillus pleuropneumoniae serovar 1 and 15 in the protection provided by sub-unit and live streptomycin-dependent pleuropneumonia vaccines.
    Tumamao JQ; Bowles RE; van den Bosch H; Klaasen HL; Fenwick BW; Blackall PJ
    Aust Vet J; 2004 Dec; 82(12):773-80. PubMed ID: 15648941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy of a subunit and a live streptomycin-dependent porcine pleuropneumonia vaccine.
    Tumamao JQ; Bowles RE; van den Bosch H; Klaasen HL; Fenwick BW; Storie GJ; Blackall PJ
    Aust Vet J; 2004 Jun; 82(6):370-4. PubMed ID: 15272463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of an affinity-purified hemolysin vaccine against experimental swine pleuropneumonia.
    Haga Y; Ogino S; Ohashi S; Ajito T; Hashimoto K; Sawada T
    J Vet Med Sci; 1997 Feb; 59(2):115-20. PubMed ID: 9070983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs.
    Shin MK; Kang ML; Jung MH; Cha SB; Lee WJ; Kim JM; Kim DH; Yoo HS
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):132-9. PubMed ID: 23206402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of pig lungs following an experimental challenge with Actinobacillus pleuropneumoniae serotype 1 and 5 in pigs inoculated with either hemolysin protein and/or outer membrane proteins.
    Madsen ME; Carnahan KG; Thwaits RN
    FEMS Microbiol Lett; 1995 Sep; 131(3):329-35. PubMed ID: 7557344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-protection between Actinobacillus pleuropneumoniae biotypes-serotypes in pigs.
    Haesebrouk F; Van de Kerkhof A; Dom P; Chiers K; Ducatelle R
    Vet Microbiol; 1996 Oct; 52(3-4):277-84. PubMed ID: 8972053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosol exposure of pigs to viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces antibodies in bronchoalveolar lining fluids and serum, and protects against homologous challenge.
    Hensel A; Stockhofe-Zurwieden N; Ganter M; Petzoldt K
    Vet Microbiol; 1995 Nov; 47(1-2):27-41. PubMed ID: 8604553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state.
    Hensel A; Huter V; Katinger A; Raza P; Strnistschie C; Roesler U; Brand E; Lubitz W
    Vaccine; 2000 Jul; 18(26):2945-55. PubMed ID: 10825595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral immunization against porcine pleuropneumonia using the cubic phase of monoolein and purified toxins of Actinobacillus pleuropneumoniae.
    Lopez-Bermudez J; Quintanar-Guerrero D; Lara Puente H; Tórtora Perez J; Suárez Güemez F; Ciprián Carrasco A; Mendoza Elvira S
    Vaccine; 2014 Nov; 32(50):6805-11. PubMed ID: 25446832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunization of pigs with viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces pulmonary and systemic antibodies and protects against homologous aerosol challenge.
    Hensel A; Stockhofe-Zurwieden N; Petzoldt K; Lubitz W
    Infect Immun; 1995 Aug; 63(8):3048-53. PubMed ID: 7622229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of mice and swine against infection with Actinobacillus pleuropneumoniae by vaccination.
    Beaudet R; McSween G; Boulay G; Rousseau P; Bisaillon JG; Descoteaux JP; Ruppanner R
    Vet Microbiol; 1994 Mar; 39(1-2):71-81. PubMed ID: 8203129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.
    van den Bosch H; Frey J
    Vaccine; 2003 Sep; 21(25-26):3601-7. PubMed ID: 12922088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of secreted virulence factors in Actinobacillus pleuropneumoniae bacterin preparation: a comparison.
    Fedorka-Cray PJ; Stine DL; Greenwald JM; Gray JT; Huether MJ; Anderson GA
    Vet Microbiol; 1993 Oct; 37(1-2):85-100. PubMed ID: 8296454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of an Actinobacillus pleuropneumoniae bacterin against serotypes 1, 3, 5 and 9.
    Tarasiuk K; Pejsak Z; Hogg A; Carlson MP
    Can Vet J; 1994 Apr; 35(4):233-8. PubMed ID: 8076279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant ApxIV protein enhances protective efficacy against Actinobacillus pleuropneumoniae in mice and pigs.
    Wu HC; Yeh PH; Hsueh KJ; Yang WJ; Chu CY
    J Appl Microbiol; 2018 Jun; 124(6):1366-1376. PubMed ID: 29431246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of conjugate vaccines against experimental challenge with porcine Actinobacillus pleuropneumoniae.
    Byrd W; Harmon BG; Kadis S
    Vet Immunol Immunopathol; 1992 Nov; 34(3-4):307-24. PubMed ID: 1455686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of immunogenicity and protective efficacy of Actinobacillus pleuropneumoniae HB04C(-) mutant lacking a drug resistance marker in the pigs.
    Bei W; He Q; Zhou R; Yan L; Huang H; Chen H
    Vet Microbiol; 2007 Nov; 125(1-2):120-7. PubMed ID: 17580102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.